United States regulator approves Roche’s Covid-19 antibody test
Through a blood sample, the test can detect antibodies to the new coronavirus, which could signal a person may have already been infected.
Copyright 2020 The Associated Press. All Rights Reserved.
The US Food and Drug Administration (FDA) has given emergency approval for use of the serological test developed by Swiss pharmaceutical giant Roche, the company announced on Sunday.
The test is designed to determine whether a person has been exposed to the new coronavirus and developed antibodies against the disease.
The Basel-based firm says that its Elecsys Anti-SARS-CoV-2 test has a specificity rate of 99.8% – which lowers the chance of false positives – and detects antibodies with 100% sensitivity.
Roche has started shipping the new test to laboratories around the world and says it plans to increase production to “high dougle-digit millions per month” to supply countries that accept the CE mark as well as the US.
Scientists worldwide are in a race to develop serological tests, as results can help policy-makers better understand the disease, determine who may have had the virus and who may have immunity, and what measures may still be needed to fight the pandemic.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
This content was published on
One in six homes in Switzerland is located in a zone threatened by natural hazards, a new study by Zürcher Kantonalbank (ZKB) has revealed.
This content was published on
The prices of owner-occupied properties continued to rise in the first three months of 2025. But large regional disparities remain.
Swiss Solidarity charity launches appeal for earthquake victims in Myanmar and Thailand
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has launched an appeal for donations for victims of the recent earthquake in Myanmar and Thailand.
Swiss finance minister to meet European counterparts to discuss trade tariffs
This content was published on
Swiss Finance Minister Karin Keller-Sutter will take part in a meeting of the EU's economics and finance (Ecofin) ministers in Warsaw, Poland, on Friday to discuss trade tariffs and economic growth in Europe.
Trump tariffs: Swiss economics minister holds talks with US trade representative
This content was published on
Swiss Economics Minister Guy Parmelin held talks with US Trade Representative Jamieson Greer on trade relations and tariffs on Monday.
US storm continues to sweep through Swiss stock market
This content was published on
The Swiss stock market continued to trade in the red mid-afternoon on Monday, following in the wake of the world's stock markets, which fell heavily as a result of the trade war launched by Donald Trump.
This content was published on
The referendum committee announced in Bern on Monday that it had collected more than 60,000 signatures against the e-ID project. The initials still need to be approved.
This content was published on
The number of offences committed by minors in canton Ticino, southern Switzerland, rose by over 20% in 2024 compared to the previous year.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What Swiss researchers are doing to beat Covid-19
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
This test could help Switzerland get back on track
This content was published on
While we await a vaccine or treatment, scientists are developing tests to tell us how widespread the virus is, such as the serological test.
Covid-19 immunity testing to begin in some Swiss hospitals
This content was published on
The hospitals are planning to roll out testing to evaluate how many people have already been infected, including those who may have already be immune.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.